Emcure API Business President Kuber Jagdale retires

Management Changes View source PDF Explain this filing

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹1840.00

prior close

₹1836.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.5%-0.8% vs market

Pharmaceuticals peers, median of 165sector-0.0%-0.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.6

15m

-0.7

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.5-0.8-0.0-0.3

Next day

+1.0+1.5-0.5+0.0+1.0

+0.4+1.6-1.2+0.5-0.1

-0.3+2.0-2.3+0.1-0.4

+0.3+1.3-1.0-0.4+0.6

-1.6-0.7-0.9-1.2-0.4

-1.6+2.2-3.9+0.0-1.6

15d

+2.2+0.8+1.4-1.4+3.6

+6.4+2.5+3.8-1.2+7.6

+0.6+3.6-3.1+1.0-0.4

+5.1-0.7+5.8+0.0+5.1

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Kuber Jagdale, President of the API Business at Emcure Pharmaceuticals, superannuates from the company effective close of business on June 30, 2026. He consequently ceases to be a Senior Management Personnel under SEBI Listing Regulations. The company has explicitly clarified this is a superannuation event and not a resignation, so no resignation letter applies. No replacement appointment has been disclosed in this filing.

Likely market impact

Planned retirement, not a sudden exit. Routine succession risk at API division; watch for a replacement announcement going forward.